Pure Global

IMBRUVICA 140 MG FILM COATED TABLET, 30 PCS - Turkey License ded6339c7e40b29f849ade9958b1b257

Access comprehensive regulatory information for IMBRUVICA 140 MG FILM COATED TABLET, 30 PCS in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number ded6339c7e40b29f849ade9958b1b257 with license number 2022/477and contains active ingredient İbrutinib. The license is held by JOHNSON AND JOHNSON SIHHİ MAL. SAN. VE TİC. LTD. ŞTİ..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
ded6339c7e40b29f849ade9958b1b257
License Details
Turkey SFDA License: ded6339c7e40b29f849ade9958b1b257
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

IMBRUVICA 140 MG FILM COATED TABLET, 30 PCS
TR: IMBRUVİCA 140 MG FİLM KAPLI TABLET, 30 ADET
Pharmaceutical Product

License Details

ded6339c7e40b29f849ade9958b1b257

2022/477

8699593095580

L01EL01

License Holder Information

Active Ingredient

İbrutinib

License Information

Aug 25, 2022